Kopa Paroxat Piller

[Thowncow]

The investigation of hydroxychloroquine as a potential treatment for chronic fatigue syndrome (CFS), given its anti-inflammatory properties, opens up new therapeutic possibilities. By targeting inflammation that may underlie some cases of CFS, hydroxychloroquine 400 mg could provide relief for patients suffering from this debilitating condition, emphasizing the need for research into its efficacy in this context.